The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5 mg/500 mg, and 12.5 mg/1000 mg.

• Overnight Stock Market Movements: Key Developments 
• KPI Green Energy Shares Rally 5% on Bagging 120 MW Order 
• Surya Roshni Rises 2.7% on Demerger Reports, US Orders
• Benchmark Indices Fell 200 Points from day High
• Apollo Micro Systems Jumps 9% on Record FY26 Profit

These tablets are used for proper diet and exercise, which improves glycemic control in adults with two types of diabetes mellitus.

Also, they are used to lower the risk of cardiovascular disease. In India, only Ahmedabad will be manufactured at the formulation facility at SEZ.